Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,821.16
-60.20(-0.12%)

Family-run Stilton maker on Brexit and copycats

'We want people to eat more cheese for breakfast'

Ascendis Pharma A/S (ASND)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

133.46

+0.33

(+0.25%)

At close: 04:00PM EDT

133.00

-0.46

(-0.34%)

After hours:

05:23PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	7.56B
Enterprise value	7.93B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	21.32
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.53
52-week change ³	38.17%
S&P500 52-week change ³	26.27%
52-week high ³	161.00
52-week low ³	83.75
50-day moving average ³	144.90
200-day moving average ³	118.33

Share statistics

Avg vol (3-month) ³	328.29k
Avg vol (10-day) ³	351.8k
Shares outstanding ⁵	56.61M
Implied shares outstanding ⁶	58.01M
Float ⁸	56.16M
% held by insiders ¹	0.76%
% held by institutions ¹	107.41%
Shares short (30 Apr 2024) ⁴	3.7M
Short ratio (30 Apr 2024) ⁴	12.42
Short % of float (30 Apr 2024) ⁴	9.41%
Short % of shares outstanding (30 Apr 2024) ⁴	6.53%
Shares short (prior month 28 Mar 2024) ⁴	3.35M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-180.51%
Operating margin (ttm)	-26.59%

Management effectiveness

Return on assets (ttm)	-29.73%
Return on equity (ttm)	-818.43%

Income statement

Revenue (ttm)	266.72M
Revenue per share (ttm)	4.74
Quarterly revenue growth (yoy)	501.40%
Gross profit (ttm)	N/A
EBITDA	-448.99M
Net income avi to common (ttm)	-481.45M
Diluted EPS (ttm)	-9.53
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	399.44M
Total cash per share (mrq)	7.05
Total debt (mrq)	644.27M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	3.56
Book value per share (mrq)	-2.57

Cash flow statement

Operating cash flow (ttm)	-467.36M
Levered free cash flow (ttm)	-318.3M